Company intelligence / Profile preview
Beijing Wellso Pharmaceutical
Beijing, Beijing, Chinasihuan.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has multiple commercialized products, including tropisetron mesylate (for chemotherapy-induced nausea and vomiting), bisoprolol fumarate (for essential hypertension), L-phencynonate hydrochloride (for motion sickness), and naltrexone hydrochloride (for opioid-related disorders).[1]
- Therapeutic areas
- OncologyNeurologyPsychiatryCardiovascular
- Modalities
- Small moleculeHerbal medicine
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Joint venture with Weihai-based pharmaceutical company
Beyond the preview
Go deeper on Beijing Wellso Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Wellso Pharmaceutical.